UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1α and Bcl-2 and Activating the Beclin 1/hVps34 Complex

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (14), p.5942-5952

2010

Link zum Volltext

Verfügbarkeit prüfen

The association between Parkinson's disease and melanoma

International journal of cancer, 2011-05, Vol.128 (10), p.2251-2260

2011

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A

Molecular cancer therapeutics, 2013-10, Vol.12 (10), p.2187-2199

2013

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease

Neuro-Signals, 2011, Vol.19 (3), p.163-174

2011

Link zum Volltext

Verfügbarkeit prüfen

Roles of autophagy in cetuximab-mediated cancer therapy against EGFR

Autophagy, 2010-11, Vol.6 (8), p.1066-1077

2010

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis

Cancer discovery, 2021-08, Vol.11 (8), p.2094-2111

2021

Link zum Volltext

Verfügbarkeit prüfen

DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

JCI insight, 2021-09, Vol.6 (17)

2021

Link zum Volltext

Verfügbarkeit prüfen

Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

Cell death & disease, 2021-07, Vol.12 (7), p.693-693, Article 693

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells

Neurochemistry international, 2010-10, Vol.57 (3), p.198-205

2010

Link zum Volltext

Verfügbarkeit prüfen

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma

The Journal of clinical investigation, 2022-12, Vol.132 (24), p.1-15

2022

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation

Cancer cell, 2010-11, Vol.18 (5), p.423-435

2010

Link zum Volltext

Verfügbarkeit prüfen

AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab

Oncotarget, 2015-05, Vol.6 (13), p.11507-11518

2015

Link zum Volltext

Verfügbarkeit prüfen

The antiepidermal growth factor receptor monoclonal antibody cetuximab C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression

Oncogene, 2005-06, Vol.24 (27), p.4433-4441

2005

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma

Molecular cancer therapeutics, 2017-04, Vol.16 (4), p.662-670

2017

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (17), p.8240-8247

2007

Link zum Volltext

Verfügbarkeit prüfen

Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α

Molecular cancer, 2007-10, Vol.6 (1), p.63-63, Article 63

2007

Link zum Volltext

Verfügbarkeit prüfen

1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy

PloS one, 2010-12, Vol.5 (12), p.e15823-e15823

2010

Link zum Volltext

Verfügbarkeit prüfen

Requirement of hypoxia-inducible factor-1α down-regulation in mediating the antitumor activity of the anti–epidermal growth factor receptor monoclonal antibody cetuximab

Molecular cancer therapeutics, 2008-05, Vol.7 (5), p.1207-1217

2008

Link zum Volltext

Verfügbarkeit prüfen

Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models

Surgery open science, 2019-10, Vol.1 (2), p.56-63

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunoproteomic analysis of the antibody response obtained in mouse following vaccination with a T-cell vaccine

Proteomics (Weinheim), 2011-11, Vol.11 (22), p.4368-4375

2011

Link zum Volltext

Verfügbarkeit prüfen

Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells

FEBS letters, 2005-12, Vol.579 (30), p.6716-6720

2005

Link zum Volltext

Verfügbarkeit prüfen

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells

Breast cancer research : BCR, 2005-01, Vol.7 (5), p.R589-R597, Article R589

2005

Link zum Volltext

Verfügbarkeit prüfen

ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis

Cancer letters, 2016-10, Vol.381 (1), p.23-30

2016

Link zum Volltext

Verfügbarkeit prüfen

Differential Roles of Phosphoinositide-Dependent Protein Kinase-1 and Akt1 Expression and Phosphorylation in Breast Cancer Cell Resistance to Paclitaxel, Doxorubicin, and Gemcitabine

Molecular pharmacology, 2006-09, Vol.70 (3), p.1045-1052

2006

Link zum Volltext

Verfügbarkeit prüfen

Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells

Anticancer research, 2014-09, Vol.34 (9), p.4685-4692

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(61)
Technology
(56)
Humans
(45)
Physical Sciences
(36)
Engineering
(35)
Oncology
(24)
Chemistry
(21)
Materials Science
(21)
Cell Line, Tumor
(19)
Female
(18)
Animals
(17)
Materials Science, Multidisciplinary
(15)
Mice
(14)
Apoptosis
(13)
Cell Biology
(12)
Cetuximab
(12)
Instruments & Instrumentation
(12)
Antineoplastic Agents - Pharmacology
(11)
Biochemistry & Molecular Biology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1α and Bcl-2 and Activating the Beclin 1/hVps34 Complex

The association between Parkinson's disease and melanoma

Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A

Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease

Roles of autophagy in cetuximab-mediated cancer therapy against EGFR

Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis

DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway

Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma

Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation

AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab

The antiepidermal growth factor receptor monoclonal antibody cetuximab C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression

Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab

Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α

1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy

Requirement of hypoxia-inducible factor-1α down-regulation in mediating the antitumor activity of the anti–epidermal growth factor receptor monoclonal antibody cetuximab

Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models

Immunoproteomic analysis of the antibody response obtained in mouse following vaccination with a T-cell vaccine

Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells

ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis

Differential Roles of Phosphoinositide-Dependent Protein Kinase-1 and Akt1 Expression and Phosphorylation in Breast Cancer Cell Resistance to Paclitaxel, Doxorubicin, and Gemcitabine

Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells

Suchergebnisse filtern